Capital Square’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $367K | Buy |
14,311
+1,693
| +13% | +$43.4K | 0.2% | 122 |
|
2025
Q1 | $320K | Buy |
12,618
+20
| +0.2% | +$507 | 0.19% | 123 |
|
2024
Q4 | $329K | Sell |
12,598
-170
| -1% | -$4.44K | 0.19% | 127 |
|
2024
Q3 | $370K | Buy |
12,768
+354
| +3% | +$10.2K | 0.22% | 113 |
|
2024
Q2 | $367K | Buy |
12,414
+473
| +4% | +$14K | 0.24% | 104 |
|
2024
Q1 | $331K | Buy |
11,941
+209
| +2% | +$5.8K | 0.23% | 103 |
|
2023
Q4 | $338K | Sell |
11,732
-4,200
| -26% | -$121K | 0.38% | 70 |
|
2023
Q3 | $500K | Sell |
15,932
-1,250
| -7% | -$39.3K | 0.67% | 45 |
|
2023
Q2 | $630K | Buy |
17,182
+533
| +3% | +$19.6K | 0.58% | 56 |
|
2023
Q1 | $691K | Buy |
16,649
+694
| +4% | +$28.8K | 0.64% | 52 |
|
2022
Q4 | $818K | Sell |
15,955
-4,648
| -23% | -$238K | 0.74% | 46 |
|
2022
Q3 | $901K | Sell |
20,603
-1,934
| -9% | -$84.6K | 0.82% | 38 |
|
2022
Q2 | $1.18M | Sell |
22,537
-6,406
| -22% | -$336K | 0.98% | 34 |
|
2022
Q1 | $1.5M | Sell |
28,943
-2,501
| -8% | -$129K | 1.07% | 24 |
|
2021
Q4 | $1.75M | Sell |
31,444
-1,802
| -5% | -$100K | 1.21% | 20 |
|
2021
Q3 | $1.43M | Sell |
33,246
-1,446
| -4% | -$62.1K | 1.01% | 30 |
|
2021
Q2 | $1.42M | Buy |
34,692
+7,821
| +29% | +$321K | 1.05% | 29 |
|
2021
Q1 | $983K | Sell |
26,871
-431
| -2% | -$15.8K | 0.73% | 43 |
|
2020
Q4 | $1M | Buy |
27,302
+618
| +2% | +$22.7K | 0.84% | 38 |
|
2020
Q3 | $929K | Buy |
26,684
+2,212
| +9% | +$77K | 0.96% | 31 |
|
2020
Q2 | $759K | Buy |
24,472
+1,125
| +5% | +$34.9K | 0.81% | 37 |
|
2020
Q1 | $723K | Buy |
23,347
+3,476
| +17% | +$108K | 0.84% | 29 |
|
2019
Q4 | $738K | Buy |
+19,871
| New | +$738K | 0.7% | 41 |
|